MF
SRRA

Magnetar Financial’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Magnetar Financial’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,106,649
Closed -$60.9K – 2042
2022
Q2 		$60.9K Buy
+1,106,649
New +$58.1M 0.63% 30

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Magnetar Financial's SRRA Position: Q3 2022 in Review

Magnetar Financial sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 1,106,649 shares — an estimated $60.9K sold.

Magnetar Financial first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $60.9K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Magnetar Financial reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Magnetar Financial sold 1,106,649 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $60.9K.
  • Magnetar Financial first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Magnetar Financial's Sierra Oncology, Inc. Common Stock position peaked at $60.9K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.